أفضل جراحو الزرع - توب -281 أطباء

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21

Dr Napasorn Tiwongkum Is A Highly Skilled Dermatologist And Hair Transplant Doctor With Extensive Expertise In FUE And DHI Hair Transplant Techniques. With A Commitment To Excellence And A Focus On Innovative Treatments, Dr Tiwongkum Has Established A Reputation For Delivering Exceptional Patient Care And Outstanding Results.

As the lead hair doctor at He Clinic, Dr Tiwongkum specialises in comprehensive hair consultations and treatments, including vitamins, medicines, serum and shampoo therapy, mesotherapy, PRP injections, and advanced stem cells for hair loss injections. 

She is adept at performing hair transplant operations utilising DHI, FUE, and Long Hair DHI techniques, ensuring provided solutions for each patient’s unique needs.

Certifications:

• 2016: Association of Cell Therapy Thailand
• 2019: NHT Hair Transplant, Turkey
• 2019: KCCS Korean College of Cosmetic Surgery, Korea
• 2019: ISHRS World Congress, Bangkok

- Completed the course in The Catholic University of Korea Yeouido St. MARY's Hospital Surgical Surgery

- The Catholic University of Korea Yeouido St. MARY's Hospital Surgical Surgery Head Chief

- Lifetime Member of the Korean Society of Surgical Surgery

- Lifetime Member of the Korean Society of  Aesthetic Surgery & Laser

- Chief Surgeon of Girin Plastic Surgery Clinic                                                                                                     

Professor Dr. Gökmen
General Surgeon

EDUCATION

• 1994: Bursa Uludağ University - Faculty of Medicine, MD
• 2000: Istanbul Okmeydanı Training and Research Hospital - General Surgery Specialization, MS

EXPERTISE

• Gastric Bypass / RNY
• Mini Gastric Bypass / MGB
• Gastric Sleeve / Fundectomy
• Gastric Banding / Bariatric Surgeries
• Gastroscopic Procedures
• Gastric Balloon Placement
• Gastric Elipse Balloon
• Gastric Botox
• Sad-S Surgery
• Distalization of RYGB
• Hernia Repair
• First and Only Operator in Turkey

TRAINING AND COURSES

• Master of Surgery:
  • Temple University School of Medicine - Laparoscopic and Bariatric Surgery Courses
  • European Institute of Telesurgery - Bariatric and Metabolic Surgery Courses (2012)
  • European Institute of Telesurgery - Advanced Colorectal Surgery Courses (2012)
  • Case Da Vinci Robotic Surgery Courses (2014)
  • Venous Diseases and Endovascular Surgery Course (2015)

MEMBERSHIPS

• UTACD: Turkish Association of Trauma and Emergency Surgery
• TSCRS: Turkish Society of Colon and Rectal Surgery
• TSA: Turkish Surgical Association

NUMBER OF CASES

• Experience of over 40,000 surgical cases in 29 years, including:
  • 20,000 Bariatric Surgeries
  • Approximately 107+ Laparoscopic Colon Resections
  • Approximately 100+ Laparoscopic Total Gastric Resections
  • Approximately 1,150+ Laparoscopic Sleeve Gastrectomies
  • Approximately 780+ Laparoscopic Mini Gastric Bypasses
  • Approximately 1,200+ Laparoscopic Roux-en-Y Gastric Bypasses
  • Approximately 1,550+ Laparoscopic Cholecystectomies

BRIEF SUMMARYOF WORK EXPERIENCE 

Including those I had transplanted during my fellowship at RUSH University in Chicago (n=86), I have performed a total of 705 liver transplants (%94 adult) both from living (%75) and cadaveric (%25) donors. And, additionally 340 kidney transplants which were mostly from living donors, too. Of these, 12 were combined liver and kidney transplantations either from cadaveric or living donors. Currently, I am the Director of Organ Transplant Program at GUVEN Hospital in Ankara. As of March 2018, here in GUVEN Hospital, we have performed 145 liver transplants (118 from living donors) with 1, 3 and 5 years patient survival of 91.2%, 86%and 83%, consecutively(ELTR data analysis). Since 1997, besides organ transplantation, I have also been operating on complicated hepato-pancreato-biliary patients